CORDIS
EU research results

CORDIS

English EN
Toll-Like Receptor 4 activation and function in diseases: an integrated chemical-biology approach.

Toll-Like Receptor 4 activation and function in diseases: an integrated chemical-biology approach.

Objective

Based on an international team derived from the COST action BM1003 (www.cost-bm1003.info, 2011-2014) and thus relying on consolidated group interactions and synergies and on a unique combination of chemistry, biology, biophysics, biochemistry and pharmacology expertise, the TOLLerant project aims to gain information on molecular aspects of TLR4 activation and signaling by using synthetic and natural compounds and nanoparticles that interact selectively with some components (mainly MD-2 and CD14) of the TRL4 recognition system.
TLR4 is an emerging molecular target related to an impressively broad spectrum of modern day disorders still lacking specific pharmacological treatment. These include autoimmune disorders, chronic inflammations, allergies, asthma, infectious and CNS diseases and cancer.
The short-term scientific objective is to develop novel, non-toxic, synthetic and natural TLR4 modulators (agonists or antagonists) and to assess their therapeutic potential on animal models of TLR4-related acute and chronic pathologies that still lack efficient pharmacological treatment. The long-term scientific objective is to develop a new generation of innovative, TLR4-based therapeutics, to be used as vaccine adjuvants, anti-sepsis agents, and anti-inflammatory agents to treat chronic inflammations (allergy, asthma). The training programme will provide Early Stage Researchers (ESR) with broad competences, experience and skills in the cutting-edge, inter-disciplinary research in the field of chemical biology related to the molecular mechanisms of innate immunity and inflammation. During the training, the young researchers will be supported by senior scientists to cultivate their scientific, entrepreneurial and inter-cultural mindset. The non-academic sector will be committed to provide ESRs with entrepreneurship and company management skills, in order to enhance their employability by the private sector or even to motivate them to create own start-up companies.

Coordinator

UNIVERSITA' DEGLI STUDI DI MILANO-BICOCCA

Address

Piazza Dell'Ateneo Nuovo 1
20126 Milano

Italy

Activity type

Higher or Secondary Education Establishments

EU Contribution

€ 516 122,64

Participants (9)

Sort alphabetically

Sort by EU Contribution

Expand all

AGENCIA ESTATAL CONSEJO SUPERIOR DEINVESTIGACIONES CIENTIFICAS

Spain

EU Contribution

€ 247 872,96

UNIVERSITAET BIELEFELD

Germany

EU Contribution

€ 249 216,48

ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN BIOMATERIALES- CIC biomaGUNE

Spain

EU Contribution

€ 247 872,96

DIOMUNE SL

Spain

EU Contribution

€ 247 872,96

KEMIJSKI INSTITUT

Slovenia

EU Contribution

€ 469 995,12

ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN BIOCIENCIAS

Spain

EU Contribution

€ 247 872,96

VIB

Belgium

EU Contribution

€ 250 560

LOFARMA S.P.A.

Italy

EU Contribution

€ 129 030,66

UNIVERSITA DEGLI STUDI DI NAPOLI FEDERICO II

Italy

EU Contribution

€ 516 122,64

Project information

Grant agreement ID: 642157

Status

Closed project

  • Start date

    1 January 2015

  • End date

    31 December 2018

Funded under:

H2020-EU.1.3.1.

  • Overall budget:

    € 3 122 539,38

  • EU contribution

    € 3 122 539,38

Coordinated by:

UNIVERSITA' DEGLI STUDI DI MILANO-BICOCCA

Italy